Health Canada releases new labelling standards for acetaminophen products
OTTAWA — One of the most commonly used pain relievers on the market is also the leading cause of all serious liver injury, Health Canada says, prompting the department to roll out updated labelling standards for acetaminophen on Thursday.
The changes include instructions on packages to encourage the use of the lowest possible dose and warnings not to use the products for more than five straight days for pain or three days for a fever.
The department also recommends that adults not exceed the recommended daily dose of 4,000 mg for adults — the equivalent of 12 regular Tylenol tablets or eight extra-strength pills.
Label changes apply immediately for companies seeking to introduce new products, but companies already on the Canadian market will have 18 months to comply.